CLINICAL RESEARCH: HEART RHYTHM DISORDERS
Paroxysmal Lone Atrial Fibrillation Is Associated With an Abnormal Atrial SubstrateCharacterizing the "Second Factor"
Martin K. Stiles, MB, ChB, PhD,
Bobby John, MD, PhD,
Christopher X. Wong,
Pawel Kuklik, PhD,
Anthony G. Brooks, PhD,
Dennis H. Lau, MBBS,
Hany Dimitri, MBBS,
Kurt C. Roberts-Thomson, MBBS, PhD,
Lauren Wilson, BSc,
Paolo De Sciscio, BSc,
Glenn D. Young, MBBS and
Prashanthan Sanders, MBBS, PhD*
Cardiovascular Research Centre, Department of Cardiology, Royal Adelaide Hospital, and the Disciplines of Medicine and Physiology, University of Adelaide, Adelaide, Australia
Manuscript received August 15, 2008;
revised manuscript received November 3, 2008,
accepted November 26, 2008.
* Reprint requests and correspondence: Dr. Prashanthan Sanders, Cardiovascular Research Centre, Department of Cardiology, Level 5 McEwin Building, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia (Email: prash.sanders{at}adelaide.edu.au).
Objectives: The purpose of this study was to determine whether patients with paroxysmal "lone" atrial fibrillation (AF) have an abnormal atrial substrate.
Background: While "AF begets AF," prompt termination to prevent electrical remodeling does not prevent disease progression.
Methods: Twenty-five patients with paroxysmal lone AF, without arrhythmia in the week prior, and 25 reference patients with left-sided accessory pathways were studied. Multipolar catheters placed at the lateral right atrium (RA), crista terminalis, coronary sinus, septal RA, and sequentially within the left atrium (LA) determined the effective refractory period (ERP) at 10 sites, conduction time along linear catheters, and conduction characteristics at the crista terminalis. Bi-atrial electroanatomic maps were created to determine regional differences in conduction velocity and voltage.
Results: Patients with AF demonstrated the following compared with reference patients: larger atrial volumes (RA: 94 ± 18 ml vs. 69 ± 9 ml, p = 0.003; LA: 99 ± 19 ml vs. 77 ± 17 ml, p = 0.006); longer ERP (at 600 ms: 255 ± 25 ms vs. 222 ± 16 ms, p < 0.001; at 450 ms: 234 ± 20 ms vs. 212 ± 14 ms, p = 0.004); longer conduction time along linear catheters (57 ± 18 ms vs. 47 ± 10 ms, p = 0.01); longer bi-atrial activation time (128 ± 17 ms vs. 89 ± 10 ms, p < 0.001); slower conduction velocity (RA: 1.3 ± 0.3 mm/ms vs. 2.1 ± 0.5 mm/ms; LA: 1.2 ± 0.2 mm/ms vs. 2.2 ± 0.4 mm/ms, p < 0.001); greater proportion of fractionated electrograms (27 ± 8% vs. 8 ± 5%, p < 0.001); longer corrected sinus node recovery time (265 ± 57 ms vs. 185 ± 60 ms, p = 0.002); and lower voltage (RA: 1.7 ± 0.4 mV vs. 2.9 ± 0.4 mV; LA: 1.7 ± 0.7 mV vs. 3.3 ± 0.7 mV, p < 0.001).
Conclusions: Patients with paroxysmal lone AF, remote from arrhythmia, demonstrate bi-atrial abnormalities characterized by structural change, conduction abnormalities, and sinus node dysfunction. These factors are likely contributors to the "second factor" that predisposes to the development and progression of AF.
Key Words: atrial fibrillation arrhythmia electrophysiology atrial remodeling atrial substrate
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CI = confidence interval | | CSNRT = corrected sinus node recovery time | | ERP = effective refractory period | | LA = left atrium/atrial | | OR = odds ratio | | RA = right atrium/atrial | | SACT = sinoatrial conduction time |
|
Related Articles
-
The "Second Factor": A First Step Toward Diagnosing the Substrate of Atrial Fibrillation?
- Maurits Allessie
J. Am. Coll. Cardiol. 2009 53: 1192-1193.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A25.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Kim, H.-N. Pak, J. H. Park, J. I. Choi, M.-H. Nam, Y. Jo, and Y.-H. Kim
Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1{alpha} mechanism
Europace,
August 1, 2009;
11(8):
1024 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Allessie
The "second factor": a first step toward diagnosing the substrate of atrial fibrillation?
J. Am. Coll. Cardiol.,
April 7, 2009;
53(14):
1192 - 1193.
[Full Text]
[PDF]
|
 |
|
|